NEW YORK, June 23 (GenomeWeb News) - Althea Technologies said today that it has received a Phase I Small Business Innovation Research grant from the National Institutes of Health, by way of the National Institute on Deafness and Other Communication Disorders, to develop a low cost mechanism for translating gene-expression-based research in toxicology into validated, high-throughput, expression screens for the asses

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.